Research & Development

The persistent struggle against lung cancer has long relied on radiation therapy to dismantle the genetic integrity of malignant cells, yet many aggressive tumors possess an uncanny ability to withstand these high-energy assaults. Recent breakthroughs from The University of Texas MD Anderson Cancer

The rapid transition of CRISPR-Cas systems from revolutionary laboratory experiments to sophisticated clinical interventions has necessitated a comprehensive overhaul of traditional safety protocols to protect patient health in the coming years. As genome editing moves beyond the initial

As a veteran analyst of the biopharmaceutical landscape, Ivan Kairatov has spent years navigating the complex intersection of clinical innovation and market dynamics. With a background rooted in deep research and development, Kairatov has become a prominent voice advocating for a paradigm shift in

The traditional understanding of Amyotrophic Lateral Sclerosis as a primarily environmental or random neurological occurrence is being systematically dismantled by recent large-scale genomic analyses that reveal a much deeper hereditary foundation than previously suspected. For decades, clinicians

The modern healthcare landscape is currently witnessing a silent revolution where the traditional boundaries between daily patient care and high-stakes clinical research are finally beginning to dissolve. For decades, the process of conducting a clinical trial was treated as a separate, often

The landscape of oncology research often hinges on the delicate balance between groundbreaking scientific discovery and the availability of sustained capital to see rigorous clinical trials through to their completion. MAIA Biotechnology has recently crossed a major financial threshold by securing